{"product_id":"rheumatoid-arthritis-clinic-owner-makes","title":"How Much Can A Rheumatoid Arthritis Clinic Owner Make With $232M Revenue?","description":"\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-plus-icon.svg\" alt=\"Key Takeaways\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eYear 1 infusion volume is the biggest revenue lever.\u003c\/li\u003e\n\n\u003cli\u003ePayer mix and denials determine net cash collected.\u003c\/li\u003e\n\n\u003cli\u003eFixed overhead sets the floor before owner pay.\u003c\/li\u003e\n\n\u003cli\u003eReserves are critical because cash gets trapped.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003csection class=\"fml-owner-metric-cards\" aria-label=\"Rheumatoid arthritis clinic\"\u003e\u003cdiv class=\"metric-grid\"\u003e\n\u003carticle class=\"metric-card is-green\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"Year 1 combines the $280k lead rheumatologist salary with $1.1M EBITDA; EBITDA is not spendable cash, and working capital can reduce take-home.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-owner-income.svg\" alt=\"Owner income icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eOwner income\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"Year 1 combines the $280k lead rheumatologist salary with $1.1M EBITDA; EBITDA is not spendable cash, and working capital can reduce take-home.\"\u003e$1.4M\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"EBITDA margin uses model EBITDA divided by revenue, from Year 1 to Year 5; it rises as fixed clinic costs get spread out.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-net-margin.svg\" alt=\"Net margin icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eNet margin\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"EBITDA margin uses model EBITDA divided by revenue, from Year 1 to Year 5; it rises as fixed clinic costs get spread out.\"\u003e48%–75%\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"Year 1 modeled annual revenue of $2.3M supports the pay case; this is collections, not cash after startup capex or reserves.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-revenue-target.svg\" alt=\"Revenue for target pay icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eRevenue for target pay\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"Year 1 modeled annual revenue of $2.3M supports the pay case; this is collections, not cash after startup capex or reserves.\"\u003e$2.3M\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card is-yellow\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"Medium because the clinic needs heavy upfront cash and multiple staff roles, but the model shows Year 1 EBITDA and Month 1 breakeven.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-business-difficulty.svg\" alt=\"Business difficulty icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eBusiness difficulty\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"Medium because the clinic needs heavy upfront cash and multiple staff roles, but the model shows Year 1 EBITDA and Month 1 breakeven.\"\u003eMedium\u003c\/strong\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWant to test your RA clinic owner pay?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-owner-calculator\" aria-label=\"Rheumatoid Arthritis Treatment Clinic Owner Income Calculator\" data-locale=\"en-US\" data-currency=\"USD\" data-default-scenario=\"base\" data-export-filename=\"Rheumatoid Arthritis Treatment Clinic Owner Income Calculator.xlsx\" data-source-site-name=\"Financial Models Lab\" data-source-site-url=\"https:\/\/financialmodelslab.com\" data-source-page-title=\"Rheumatoid Arthritis Treatment Clinic Owner Income Calculator\" data-note-title=\"Planning note:\" data-note-text=\"Research-based planning estimate only. It is not guaranteed salary, tax advice, or owner distribution advice.\"\u003e\u003cdiv class=\"fml-owner-card\"\u003e\n\u003cheader class=\"fml-owner-header\"\u003e\u003cdiv class=\"fml-owner-heading\"\u003e\n\u003cp class=\"fml-owner-eyebrow\"\u003eOwner income calculator\u003c\/p\u003e\n\u003cp class=\"fml-owner-intro\"\u003eEstimate owner take-home and target-pay gap from monthly revenue, gross margin, staffing cost, overhead, reserves, and target pay.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-scenarios\" aria-label=\"Income scenario presets\"\u003e\n\u003cbutton class=\"fml-owner-scenario\" type=\"button\" data-scenario=\"low\"\u003eLow\u003c\/button\u003e\u003cbutton class=\"fml-owner-scenario is-active\" type=\"button\" data-scenario=\"base\"\u003eBase\u003c\/button\u003e\u003cbutton class=\"fml-owner-scenario\" type=\"button\" data-scenario=\"high\"\u003eHigh\u003c\/button\u003e\n\u003c\/div\u003e\u003c\/header\u003e\u003cdiv class=\"fml-owner-layout\"\u003e\n\u003cform class=\"fml-owner-inputs\"\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eMonthly revenue\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Collected cash in an average operating month after payer collections, not a one-time peak month.\"\u003ei\u003cspan role=\"tooltip\"\u003eCollected cash in an average operating month after payer collections, not a one-time peak month.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"monthlyRevenue\" data-owner-kind=\"money\" data-owner-label=\"Monthly revenue\" data-owner-note=\"Collected cash in an average operating month after payer collections, not a one-time peak month.\" data-low=\"165000\" data-base=\"193000\" data-high=\"230000\" name=\"monthlyRevenue\" type=\"text\" inputmode=\"numeric\" value=\"193,000\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eGross margin\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of revenue left after direct care costs, biologic inventory, supplies, and billing fees.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of revenue left after direct care costs, biologic inventory, supplies, and billing fees.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"grossMargin\" data-owner-kind=\"percent\" data-owner-label=\"Gross margin\" data-owner-note=\"Percent of revenue left after direct care costs, biologic inventory, supplies, and billing fees.\" name=\"grossMargin\" type=\"range\" min=\"0\" max=\"100\" step=\"1\" data-low=\"74\" data-base=\"79\" data-high=\"82\" value=\"79\"\u003e\u003coutput\u003e79%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eLabor cost\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly payroll for clinicians and clinic staff before owner pay.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly payroll for clinicians and clinic staff before owner pay.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"laborCost\" data-owner-kind=\"money\" data-owner-label=\"Labor cost\" data-owner-note=\"Monthly payroll for clinicians and clinic staff before owner pay.\" data-low=\"48000\" data-base=\"52000\" data-high=\"59000\" name=\"laborCost\" type=\"text\" inputmode=\"numeric\" value=\"52,000\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eFixed overhead\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Lease, malpractice, IT, utilities, admin, and licensing costs.\"\u003ei\u003cspan role=\"tooltip\"\u003eLease, malpractice, IT, utilities, admin, and licensing costs.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"fixedOverhead\" data-owner-kind=\"money\" data-owner-label=\"Fixed overhead\" data-owner-note=\"Lease, malpractice, IT, utilities, admin, and licensing costs.\" data-low=\"24900\" data-base=\"24900\" data-high=\"24900\" name=\"fixedOverhead\" type=\"text\" inputmode=\"numeric\" value=\"24,900\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eMarketing\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly patient marketing and digital ads needed to sustain visit volume.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly patient marketing and digital ads needed to sustain visit volume.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"marketing\" data-owner-kind=\"money\" data-owner-label=\"Marketing\" data-owner-note=\"Monthly patient marketing and digital ads needed to sustain visit volume.\" data-low=\"8000\" data-base=\"9600\" data-high=\"12000\" name=\"marketing\" type=\"text\" inputmode=\"numeric\" value=\"9,600\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eDebt service\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly loan or financing payments; use 0 if there is no debt.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly loan or financing payments; use 0 if there is no debt.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"debtService\" data-owner-kind=\"money\" data-owner-label=\"Debt service\" data-owner-note=\"Monthly loan or financing payments; use 0 if there is no debt.\" data-low=\"0\" data-base=\"0\" data-high=\"0\" name=\"debtService\" type=\"text\" inputmode=\"numeric\" value=\"\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eTax reserve\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of profit held back before owner take-home.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of profit held back before owner take-home.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"taxReserve\" data-owner-kind=\"percent\" data-owner-label=\"Tax reserve\" data-owner-note=\"Percent of profit held back before owner take-home.\" name=\"taxReserve\" type=\"range\" min=\"0\" max=\"45\" step=\"1\" data-low=\"20\" data-base=\"24\" data-high=\"26\" value=\"24\"\u003e\u003coutput\u003e24%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eReinvestment reserve\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of profit retained for growth, repairs, working capital, and risk buffer.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of profit retained for growth, repairs, working capital, and risk buffer.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"reinvestmentReserve\" data-owner-kind=\"percent\" data-owner-label=\"Reinvestment reserve\" data-owner-note=\"Percent of profit retained for growth, repairs, working capital, and risk buffer.\" name=\"reinvestmentReserve\" type=\"range\" min=\"0\" max=\"35\" step=\"1\" data-low=\"8\" data-base=\"10\" data-high=\"12\" value=\"10\"\u003e\u003coutput\u003e10%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eTarget owner pay\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly owner pay target used to calculate the target-pay gap.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly owner pay target used to calculate the target-pay gap.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"targetOwnerPay\" data-owner-kind=\"money\" data-owner-label=\"Target owner pay\" data-owner-note=\"Monthly owner pay target used to calculate the target-pay gap.\" data-low=\"15000\" data-base=\"23333\" data-high=\"30000\" name=\"targetOwnerPay\" type=\"text\" inputmode=\"numeric\" value=\"23,333\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/form\u003e\n\u003caside class=\"fml-owner-results\" aria-live=\"polite\"\u003e\u003cspan class=\"fml-owner-tag\"\u003eOwner income output\u003c\/span\u003e\u003cdiv class=\"fml-owner-metrics\"\u003e\n\u003cdiv class=\"fml-owner-metric is-primary\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eOwner Income\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly take-home after tax and reinvestment reserves.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly take-home after tax and reinvestment reserves.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"monthlyOwnerIncome\"\u003e$43,540\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eNet Margin\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Owner income divided by monthly revenue.\"\u003ei\u003cspan role=\"tooltip\"\u003eOwner income divided by monthly revenue.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"netProfitMargin\"\u003e23%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eRevenue for Target Pay\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly revenue needed to support the target owner pay.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly revenue needed to support the target owner pay.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"revenueNeeded\"\u003e$154K\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric is-target-gap is-positive\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eTarget Pay Gap\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Owner income minus target owner pay. Negative means the target pay is not covered.\"\u003ei\u003cspan role=\"tooltip\"\u003eOwner income minus target owner pay. Negative means the target pay is not covered.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"targetPayGap\"\u003e$20,207\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdl class=\"fml-owner-result-list\"\u003e\n\u003cdiv\u003e\n\u003cdt\u003eAnnual owner income\u003c\/dt\u003e\n\u003cdd data-owner-output=\"annualOwnerIncome\"\u003e$522,480\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eProfit before reserves\u003c\/dt\u003e\n\u003cdd data-owner-output=\"profitBeforeReserves\"\u003e$65,970\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eTax + reinvestment reserve\u003c\/dt\u003e\n\u003cdd data-owner-output=\"reserveAmount\"\u003e$22,430\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eTarget pay gap\u003c\/dt\u003e\n\u003cdd data-owner-output=\"cashAfterTargetPay\"\u003e$20,207\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003c\/dl\u003e\n\u003cdiv class=\"fml-owner-bridge\"\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"revenue\"\u003e\n\u003cspan\u003eRevenue\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 100%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$193K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"grossProfit\"\u003e\n\u003cspan\u003eGross profit\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 79%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$152K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"operatingCosts\"\u003e\n\u003cspan\u003eOperating costs\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 45%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$86,500\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"reserveAmount\"\u003e\n\u003cspan\u003eReserves\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 12%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$22,430\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"ownerIncome\"\u003e\n\u003cspan\u003eOwner income\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 23%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$43,540\u003c\/b\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"fml-owner-export\" type=\"button\" data-owner-export\u003eEXPORT XLSX\u003c\/button\u003e\u003c\/aside\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-note\"\u003e\n\u003cspan class=\"fml-owner-note-icon\" aria-hidden=\"true\"\u003e!\u003c\/span\u003e\u003cp\u003e\u003cstrong\u003ePlanning note:\u003c\/strong\u003e Research-based planning estimate only. It is not guaranteed salary, tax advice, or owner distribution advice.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003cbr\u003e\u003cdiv class=\"container_new_design_blog\"\u003e\n\n\u003cdiv class=\"text-section_blog text-2_new_design_blog\"\u003e\n\n\u003cdiv class=\"line_top_blog\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\n\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eWant to check owner income in the Rheumatoid Arthritis Treatment Clinic model?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp\u003eScreenshot shows revenue, margin, costs, reserves, and owner take-home assumptions in \u003ca href=\"\/products\/rheumatoid-arthritis-clinic-financial-model\"\u003eRheumatoid Arthritis Treatment Clinic Financial Model Template\u003c\/a\u003e. It also maps \u003cstrong\u003e$232M to $1,233M\u003c\/strong\u003e revenue, \u003cstrong\u003e$912k to $922M\u003c\/strong\u003e EBITDA, and \u003cstrong\u003e$285k\u003c\/strong\u003e startup capex. Open it to test scenarios.\u003c\/p\u003e\n\n\u003ch4\u003eOwner-income model highlights\u003c\/h4\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eOwner take-home outputs\u003c\/li\u003e\n\u003cli\u003eRevenue and EBITDA charts\u003c\/li\u003e\n\u003cli\u003eScenario tests on inputs\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003cdiv class=\"image-section_blog image-2_new_design_blog\"\u003e\n\n\u003cdiv class=\"preview-card\" data-preview-src=\"\/cdn\/shop\/files\/rheumatoid-arthritis-clinic-financial-model-dashboard-financialmodelslab_87568f0e-30dc-404e-8452-79f0d9f1bf49.webp\"\u003e\n\u003cimg class=\"preview-img\" width=\"100%\" height=\"auto\" src=\"\/cdn\/shop\/files\/rheumatoid-arthritis-clinic-financial-model-dashboard-financialmodelslab_87568f0e-30dc-404e-8452-79f0d9f1bf49.webp?width=500\" alt=\"Rheumatoid Arthritis Treatment Clinic Financial Model dashboard summarizing key KPIs, runway\/cash and operational performance with a dynamic dashboard for investor-ready reporting and cash-flow clarity\"\u003e\n\u003cdiv class=\"preview-overlay\"\u003e\n\u003cbutton class=\"preview-btn\" type=\"button\" style=\"align-items: center; vertical-align: middle; display: inline-flex; justify-content: center; gap: 6px; line-height: 1;\"\u003e\nPREVIEW \u003csvg fill=\"#fff\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\" role=\"presentation\" viewbox=\"0 0 448 512\" width=\"14\"\u003e\u003cpath d=\"M416 176V86.63L246.6 256L416 425.4V336c0-8.844 7.156-16 16-16s16 7.156 16 16v128c0 8.844-7.156 16-16 16h-128c-8.844 0-16-7.156-16-16s7.156-16 16-16h89.38L224 278.6L54.63 448H144C152.8 448 160 455.2 160 464S152.8 480 144 480h-128C7.156 480 0 472.8 0 464v-128C0 327.2 7.156 320 16 320S32 327.2 32 336v89.38L201.4 256L32 86.63V176C32 184.8 24.84 192 16 192S0 184.8 0 176v-128C0 39.16 7.156 32 16 32h128C152.8 32 160 39.16 160 48S152.8 64 144 64H54.63L224 233.4L393.4 64H304C295.2 64 288 56.84 288 48S295.2 32 304 32h128C440.8 32 448 39.16 448 48v128C448 184.8 440.8 192 432 192S416 184.8 416 176z\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow much can a rheumatoid arthritis clinic owner take home after expenses?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eA Rheumatoid Arthritis Treatment Clinic owner can take home the included \u003cstrong\u003e$280k owner-clinician salary\u003c\/strong\u003e, plus a possible draw from \u003cstrong\u003e$912k EBITDA\u003c\/strong\u003e after taxes, debt service, reserves, and reinvestment; for cost context, see \u003ca href=\"\/blogs\/operating-costs\/rheumatoid-arthritis-clinic\"\u003eWhat Are Operating Costs For Rheumatoid Arthritis Treatment Clinic?\u003c\/a\u003e. Here’s the quick math: \u003cstrong\u003e$912k EBITDA\u003c\/strong\u003e on \u003cstrong\u003e$232M revenue\u003c\/strong\u003e equals a \u003cstrong\u003e0.39% EBITDA margin\u003c\/strong\u003e, so cash discipline matters.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTake-home view\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e$280k salary\u003c\/strong\u003e is already in payroll\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$912k EBITDA\u003c\/strong\u003e funds any extra draw\u003c\/li\u003e\n\u003cli\u003ePay taxes before owner distributions\u003c\/li\u003e\n\u003cli\u003eHold reserves for clinic cash flow\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCost guardrails\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e$249k\/month\u003c\/strong\u003e listed fixed overhead\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$620k\/year\u003c\/strong\u003e listed payroll\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e21%\u003c\/strong\u003e Year 1 variable costs\u003c\/li\u003e\n\u003cli\u003eModel added hired-clinician payroll separately\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow many patients does a rheumatoid arthritis clinic need to pay the owner?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eThe clinic can’t be sized by patient count alone; it needs about \u003cstrong\u003e366 encounters a month\u003c\/strong\u003e to cover fixed payroll and overhead, and about \u003cstrong\u003e486 encounters a month\u003c\/strong\u003e if the owner also wants \u003cstrong\u003e$300k a year\u003c\/strong\u003e. At the Year 1 model, monthly revenue is about \u003cstrong\u003e$1.932M\u003c\/strong\u003e from roughly \u003cstrong\u003e729 treatment encounters\u003c\/strong\u003e, or about \u003cstrong\u003e$265\u003c\/strong\u003e blended revenue per encounter.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBreak-even math\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e$766k\u003c\/strong\u003e fixed payroll and overhead\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e79%\u003c\/strong\u003e contribution margin\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$969k\u003c\/strong\u003e monthly collections to break even\u003c\/li\u003e\n\u003cli\u003eAbout \u003cstrong\u003e366 encounters\u003c\/strong\u003e per month\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOwner pay target\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAdd \u003cstrong\u003e$300k\u003c\/strong\u003e annual distribution\u003c\/li\u003e\n\u003cli\u003eNeeded collections rise to \u003cstrong\u003e$1.286M\u003c\/strong\u003e monthly\u003c\/li\u003e\n\u003cli\u003eThat is about \u003cstrong\u003e486 encounters\u003c\/strong\u003e per month\u003c\/li\u003e\n\u003cli\u003ePayer mix and no-shows change the math\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eDoes in-office infusion increase rheumatoid arthritis clinic owner income?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eYes, it can boost owner income for a \u003ca href=\"\/blogs\/how-to-open\/rheumatoid-arthritis-clinic\"\u003eRheumatoid Arthritis Treatment Clinic\u003c\/a\u003e, but only if reimbursement, drug-cost timing, authorization work, and chair use all hold up. In the model, \u003cstrong\u003eYear 1 infusion revenue\u003c\/strong\u003e is \u003cstrong\u003e$96k per month\u003c\/strong\u003e, nearly half of total monthly revenue, and \u003cstrong\u003eYear 5\u003c\/strong\u003e infusion revenue reaches \u003cstrong\u003e$5355k per month\u003c\/strong\u003e. The catch is cash: specialty biologic drug inventory is modeled at \u003cstrong\u003e85%\u003c\/strong\u003e of revenue in Year 1 and \u003cstrong\u003e75%\u003c\/strong\u003e in Year 5, so higher acquisition costs or delayed collections can drain cash fast.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRevenue drivers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e$96k\u003c\/strong\u003e monthly in Year 1\u003c\/li\u003e\n\u003cli\u003eNearly half of monthly revenue\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$5355k\u003c\/strong\u003e monthly in Year 5\u003c\/li\u003e\n\u003cli\u003eModel the infusion line separately\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCash risk points\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e85%\u003c\/strong\u003e inventory in Year 1\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e75%\u003c\/strong\u003e inventory in Year 5\u003c\/li\u003e\n\u003cli\u003eDelayed collections can squeeze cash\u003c\/li\u003e\n\u003cli\u003eAuthorization delays slow chair use\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\n\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat drives RA clinic owner income most?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-main-income-drivers\" aria-label=\"Main Income Drivers for a rheumatoid arthritis treatment clinic.\"\u003e\u003carticle class=\"driver-option is-cards\"\u003e\u003cdiv class=\"main-driver-grid\"\u003e\n\u003carticle class=\"main-driver-card is-primary\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e1\u003c\/span\u003e\u003ch4\u003eProvider Capacity\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$2.3M\u003c\/strong\u003e\u003cp\u003eYear 1 revenue is $2.318M at 65% rheumatologist capacity and 50% infusion nurse capacity, so filled slots drive the fastest lift in owner cash.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e2\u003c\/span\u003e\u003ch4\u003eInfusion Economics\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$1.2K\u003c\/strong\u003e\u003cp\u003eInfusion visits price at $1,200 in Year 1, so keeping the infusion suite busy can add more EBITDA than low-ticket care.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e3\u003c\/span\u003e\u003ch4\u003eMargin Rate\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e21%\u003c\/strong\u003e\u003cp\u003eCOGS and variable spend run about 21% in Year 1, so tighter billing, claims, and supply control drops straight to take-home.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e4\u003c\/span\u003e\u003ch4\u003ePayroll Load\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$620K\u003c\/strong\u003e\u003cp\u003eYear 1 payroll is about $620K, so staffing the right mix keeps growth from getting eaten by labor.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e5\u003c\/span\u003e\u003ch4\u003eFixed Overhead\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$24.9K\/mo\u003c\/strong\u003e\u003cp\u003eFixed overhead is about $24.9K per month, so lease, insurance, IT, and admin discipline protect reserves and distributions.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e6\u003c\/span\u003e\u003ch4\u003eOwner Payout\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e43.9%\u003c\/strong\u003e\u003cp\u003eWith a 43.89% IRR and one-month payback, the owner can balance draw, reserves, and reinvestment without choking growth.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/article\u003e\u003c\/section\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eRheumatoid Arthritis Treatment Clinic Core Six Income Drivers\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eProvider Capacity And Patient Volume\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n\u003cdiv class=\"left-row1\"\u003e\n\u003ch3\u003eProvider Capacity And Visit Volume\u003c\/h3\u003e\n\u003cp\u003eWhen more scheduled visits are actually completed, collections rise fast because most overhead does not move line by line. At Year 1 levels, \u003cstrong\u003e208 monthly rheumatology visits\u003c\/strong\u003e at \u003cstrong\u003e$250\u003c\/strong\u003e each and \u003cstrong\u003e80 monthly infusion treatments\u003c\/strong\u003e at \u003cstrong\u003e$1,200\u003c\/strong\u003e each produce about \u003cstrong\u003e$148,000 per month\u003c\/strong\u003e before overhead and staffing pressure.\u003c\/p\u003e\n\u003cp\u003eThis driver includes show rate, follow-up cadence, new-patient access, and schedule gaps. \u003cstrong\u003eNo-shows\u003c\/strong\u003e and empty slots cut revenue right away, while moving capacity toward Year 5 levels can lift income materially. The catch: volume only helps if billing, staffing, and clinical quality keep pace, or owner pay can get squeezed by rework and delays.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"right-row1\"\u003e\n\u003cdiv class=\"tips-box\"\u003e\n\u003ch3\u003eTrack Filled Slots, Not Just Open Slots\u003c\/h3\u003e\n\u003cp\u003eHere’s the quick math: \u003cstrong\u003e208 visits × $250 = $52,000\u003c\/strong\u003e and \u003cstrong\u003e80 treatments × $1,200 = $96,000\u003c\/strong\u003e. So the real target is completed care, not booked calendar time. Track completed visits, infusion chair use, no-show rate, and time from referral to first visit, because those are the levers that move cash into the business.\u003c\/p\u003e\n\u003cp\u003eUse a weekly schedule review to spot gaps, late cancels, and slow follow-up. If access is tight or the calendar is fragmented, revenue softens even when demand is there. \u003cstrong\u003eOne clean rule: every empty slot is lost collection\u003c\/strong\u003e, unless the team has a fast way to refill it and bill it cleanly.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMeasure completed visits, not bookings.\u003c\/li\u003e\n\u003cli\u003eWatch no-shows and open gaps.\u003c\/li\u003e\n\u003cli\u003eProtect infusion chair and nurse time.\u003c\/li\u003e\n\u003cli\u003eKeep billing and staffing aligned.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"step-circle step1\"\u003e1\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003ePayer Mix And Net Collections\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"right-row2\"\u003e\n    \u003ch3\u003ePayer Mix And Net Collections\u003c\/h3\u003e\n    \u003cp\u003eOwner pay follows \u003cstrong\u003ecash collected\u003c\/strong\u003e, not billed charges. With prices from \u003cstrong\u003e$75\u003c\/strong\u003e clinical assistant encounters to \u003cstrong\u003e$1,200\u003c\/strong\u003e Year 1 infusion treatments, payer mix, \u003cstrong\u003eMedicare\u003c\/strong\u003e share, prior authorization, denials, and billing speed can move take-home income fast. Billing and claims fees are modeled at \u003cstrong\u003e30%\u003c\/strong\u003e of revenue in \u003cstrong\u003eYears 1–2\u003c\/strong\u003e, then \u003cstrong\u003e25%\u003c\/strong\u003e by \u003cstrong\u003eYear 5\u003c\/strong\u003e.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"left-row2\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTest Reimbursement Before You Add Infusion\u003c\/h3\u003e\n      \u003cp\u003eTrack \u003cstrong\u003epayer mix\u003c\/strong\u003e, \u003cstrong\u003edenial rate\u003c\/strong\u003e, \u003cstrong\u003edays in A\/R\u003c\/strong\u003e (days to collect cash), and net collections per visit. If a service collects \u003cstrong\u003e$100\u003c\/strong\u003e, a \u003cstrong\u003e30%\u003c\/strong\u003e billing fee leaves \u003cstrong\u003e$70\u003c\/strong\u003e before other clinic costs. \u003cstrong\u003eLocal reimbursement assumptions must be tested before hiring or expanding infusion.\u003c\/strong\u003e Slow auth or weak contracts can delay distributions even when visit volume looks strong.\u003c\/p\u003e\n      \u003cul class=\"lst_crct_blog\"\u003e\n        \u003cli\u003eMedicare share and contract rates\u003c\/li\u003e\n        \u003cli\u003eAuthorization turnaround time\u003c\/li\u003e\n        \u003cli\u003eDenial rate and appeal lag\u003c\/li\u003e\n        \u003cli\u003eDays in A\/R and posting speed\u003c\/li\u003e\n      \u003c\/ul\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step2\"\u003e2\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eIn-Office Infusion Economics\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"left-row3\"\u003e\n    \u003ch3\u003eInfusion Revenue and Cash Flow\u003c\/h3\u003e\n    \u003cp\u003eInfusion is the biggest revenue lever here, but it’s also the biggest cash-flow risk. Year 1 assumes \u003cstrong\u003e$96k per month\u003c\/strong\u003e from \u003cstrong\u003e2 infusion nurses\u003c\/strong\u003e at \u003cstrong\u003e50% capacity\u003c\/strong\u003e; by Year 5, the model rises to \u003cstrong\u003e$5,355k per month\u003c\/strong\u003e with \u003cstrong\u003e5 nurses\u003c\/strong\u003e at \u003cstrong\u003e85% capacity\u003c\/strong\u003e. Owner pay only grows if that volume turns into clean collections, not just billed charges.\u003c\/p\u003e\n    \u003cp\u003eThe pressure point is the drug cash tied up before payment clears. Biologic inventory is modeled at \u003cstrong\u003e85% of revenue\u003c\/strong\u003e in Year 1 and \u003cstrong\u003e75% in Year 5\u003c\/strong\u003e. So if authorizations slow, chairs sit empty, or nursing coverage breaks, revenue drops fast while inventory and labor still hit cash. That can shrink distributions even when the clinic looks busy.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"right-row3\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack Drug Cash and Chair Use\u003c\/h3\u003e\n      \u003cp\u003eMeasure \u003cstrong\u003ecapacity by nurse\u003c\/strong\u003e, \u003cstrong\u003echair utilization\u003c\/strong\u003e, authorization lag, denial rate, and days in inventory. These inputs tell you if infusion is producing spendable profit or just tying up cash. Model each payer separately, since payer spread changes both margin and the speed of collections.\u003c\/p\u003e\n      \u003cp\u003eDo not add chairs or nurses until monthly collections beat drug purchases and staffing cost. If authorizations slip, the clinic can show strong revenue on paper and still run short on cash for owner draws. One clean metric beats a dozen hopeful ones.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step3\"\u003e3\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eStaffing Efficiency And Clinical Labor\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"right-row4\"\u003e\n    \u003ch3\u003eStaffing Efficiency and Clinical Labor\u003c\/h3\u003e\n    \u003cp\u003eIf payroll does not turn into \u003cstrong\u003ecompleted visits\u003c\/strong\u003e and \u003cstrong\u003eclean claims\u003c\/strong\u003e, it turns into dead weight. Listed payroll rises from \u003cstrong\u003e$620k\u003c\/strong\u003e in Year 1 to \u003cstrong\u003e$730k\u003c\/strong\u003e in Years 3 and 4, then \u003cstrong\u003e$775k\u003c\/strong\u003e in Year 5, so the clinic has to keep schedules full across clinical and front-office staff.\u003c\/p\u003e\n    \u003cp\u003eThe key test is simple: paid labor must produce billable work fast enough to support \u003cstrong\u003eowner distributions\u003c\/strong\u003e. Roles include a lead rheumatologist, clinic director, receptionists, care coordinator, and billing manager, plus rheumatologists, infusion nurses, physical therapists, occupational therapists, and clinical assistants. If added clinician payroll is missing from the wage schedule, add it before sizing profit.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"left-row4\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack Labor per Billable Visit\u003c\/h3\u003e\n      \u003cp\u003eMeasure \u003cstrong\u003ecompleted visits per staffed hour\u003c\/strong\u003e, \u003cstrong\u003eclaim clean rate\u003c\/strong\u003e, no-shows, and the share of payroll tied to direct care versus admin. Those inputs show whether labor is supporting revenue or just adding fixed cost.\u003c\/p\u003e\n      \u003cul class=\"lst_crct_blog\"\u003e\n        \u003cli\u003eTrack visits by role each week\u003c\/li\u003e\n        \u003cli\u003eSeparate direct care and admin payroll\u003c\/li\u003e\n        \u003cli\u003eLog claim errors and resubmits\u003c\/li\u003e\n        \u003cli\u003eAdd missing clinician wages first\u003c\/li\u003e\n      \u003c\/ul\u003e\n      \u003cp\u003eWhen volume softens, cut schedule gaps before cutting core clinical coverage. When billing slows, cash gets trapped even if visits happened, and owner pay comes later.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step4\"\u003e4\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eFixed Overhead And Operating Costs\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n\u003cdiv class=\"left-row5\"\u003e\n\u003ch3\u003eFixed Overhead Floor\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eFixed overhead\u003c\/strong\u003e is the monthly bill the clinic pays before the owner sees any pay. Here, that floor is \u003cstrong\u003e$249k per month\u003c\/strong\u003e, including \u003cstrong\u003e$12k\u003c\/strong\u003e lease, \u003cstrong\u003e$65k\u003c\/strong\u003e malpractice, \u003cstrong\u003e$22k\u003c\/strong\u003e EHR and IT, \u003cstrong\u003e$18k\u003c\/strong\u003e utilities, \u003cstrong\u003e$900\u003c\/strong\u003e supplies, and \u003cstrong\u003e$15k\u003c\/strong\u003e licensing. These costs do not fall much when visit volume dips, so they set the minimum cash the clinic must collect each month.\u003c\/p\u003e\n\u003cp\u003eOne clean rule: if collections do not clear the \u003cstrong\u003e$249k\u003c\/strong\u003e floor, owner income gets squeezed fast. Keep \u003cstrong\u003edrug costs\u003c\/strong\u003e and \u003cstrong\u003eclinical supplies\u003c\/strong\u003e separate, because mixing them into overhead will hide the real margin. In Year 1, the extra load from \u003cstrong\u003e50%\u003c\/strong\u003e marketing and \u003cstrong\u003e30%\u003c\/strong\u003e billing also cuts into cash left for salary, reserves, and distributions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"right-row5\"\u003e\n\u003cdiv class=\"tips-box\"\u003e\n\u003ch3\u003eTrack the Floor, Then Price for It\u003c\/h3\u003e\n\u003cp\u003eMeasure monthly \u003cstrong\u003ecollections\u003c\/strong\u003e, \u003cstrong\u003efixed overhead\u003c\/strong\u003e, and \u003cstrong\u003evariable billing and marketing costs\u003c\/strong\u003e in the same view. The key test is simple: do net collections after direct clinical costs still clear the \u003cstrong\u003e$249k\u003c\/strong\u003e floor and leave room for owner pay? If not, the clinic may be busy but still not profitable enough to pay the owner well.\np\u0026gt;\n\u003c\/p\u003e\n\u003cp\u003eControl the big lines first: lease, malpractice, EHR and IT, utilities, licensing, and staff support. Then watch whether higher visit volume improves cash or just raises billing and marketing spend. If collections lag behind visits, tighten denial follow-up, reduce wasted seats, and forecast cash weekly so the owner can see when distributions are safe.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"step-circle step5\"\u003e5\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eOwner Role, Reserves, And Distributions\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"right-row6\"\u003e\n    \u003ch3\u003eOwner Salary, Reserves, And Draws\u003c\/h3\u003e\n    \u003cp\u003eOwner take-home here comes from \u003cstrong\u003e$280k\u003c\/strong\u003e lead salary plus any distribution from EBITDA. The model shows \u003cstrong\u003eYear 1 EBITDA of about $912k\u003c\/strong\u003e before taxes, debt service, reserves, and reinvestment, so cash pay can be much lower than profit on paper. \u003cstrong\u003eEBITDA is not spendable owner income.\u003c\/strong\u003e\u003c\/p\u003e\n    \u003cp\u003eWhat matters is cash left after infusion inventory, delayed collections, and the cash reserve the clinic keeps on hand. The model’s \u003cstrong\u003eYear 5 EBITDA is listed at $922M\u003c\/strong\u003e, but the real question is how much stays in the bank after working capital and debt service.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"left-row6\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eSet A Distribution Floor First\u003c\/h3\u003e\n      \u003cp\u003eTrack three inputs every month: \u003cstrong\u003esalary\u003c\/strong\u003e, \u003cstrong\u003ecash reserve target\u003c\/strong\u003e, and \u003cstrong\u003efree cash after inventory and collections\u003c\/strong\u003e. If collections lag or infusion stock ties up cash, keep distributions low even when EBITDA looks strong. That keeps the owner paid without starving the clinic.\u003c\/p\u003e\n      \u003cul class=\"lst_crct_blog\"\u003e\n        \u003cli\u003ePay salary before draws.\u003c\/li\u003e\n        \u003cli\u003eHold a reserve for delays.\u003c\/li\u003e\n        \u003cli\u003eReview cash after billing.\u003c\/li\u003e\n        \u003cli\u003eLimit draws during inventory spikes.\u003c\/li\u003e\n      \u003c\/ul\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step6\"\u003e6\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eCompare lean, base, and high RA clinic income scenarios\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-scenario-table\" aria-label=\"Rheumatoid Arthritis Treatment Clinic Owner Income Scenarios\" data-site-name=\"Financial Models Lab\" data-site-url=\"https:\/\/financialmodelslab.com\" data-source-title=\"Rheumatoid Arthritis Treatment Clinic Owner Income Scenarios\" data-note-label=\"Planning note\" data-note-text=\"Scenario ranges are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.\"\u003e\u003cdiv class=\"fml-scenario-table-card\"\u003e\n\u003cheader class=\"fml-scenario-table-header\"\u003e\u003cdiv\u003e\n\u003cp class=\"fml-scenario-table-eyebrow\"\u003eOwner income scenarios\u003c\/p\u003e\n\u003cp class=\"fml-scenario-table-description\"\u003eOwner income moves with service mix, staffing, and infusion volume. The low case keeps the clinic lean; the high case tracks toward Year 5 scale.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-scenario-table-actions\"\u003e\u003cbutton class=\"fml-scenario-table-export\" type=\"button\" data-scenario-export\u003eEXPORT XLSX\u003c\/button\u003e\u003c\/div\u003e\u003c\/header\u003e\u003cdiv class=\"fml-scenario-table-wrap\"\u003e\u003ctable class=\"fml-scenario-table-grid\"\u003e\n\u003ccaption\u003eLow, base, and high owner income cases for planning.\u003c\/caption\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth class=\"fml-scenario-table-stub\" scope=\"col\" data-export-value=\"Scenario\"\u003eScenario\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"Low Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eLow Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eDownside\u003c\/span\u003e\n\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"Base Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eBase Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eBase\u003c\/span\u003e\n\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"High Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eHigh Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-warning\"\u003eUpside\u003c\/span\u003e\n\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Launch model\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-launch\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-launch-model.svg\" alt=\"Launch model icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eLaunch model\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"This is the conservative earnings path if the clinic stays consult-heavy and infusion volume remains modest.\"\u003eThis is the conservative earnings path if the clinic stays consult-heavy and infusion volume remains modest.\u003c\/td\u003e\n\u003ctd data-export-value=\"This is the modeled middle path using the Year 1 operating plan.\"\u003eThis is the modeled middle path using the Year 1 operating plan.\u003c\/td\u003e\n\u003ctd data-export-value=\"This is the stronger earnings path if the clinic scales toward the Year 5 operating plan.\"\u003eThis is the stronger earnings path if the clinic scales toward the Year 5 operating plan.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Typical setup\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-setup\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-typical-setup.svg\" alt=\"Typical setup icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eTypical setup\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Keeps infusion use low, runs tighter staffing, and stays below the Year 1 capacity buildout while protecting cash flow.\"\u003eKeeps infusion use low, runs tighter staffing, and stays below the Year 1 capacity buildout while protecting cash flow.\u003c\/td\u003e\n\u003ctd data-export-value=\"Runs with 2 rheumatologists, 2 infusion nurses, 1 physical therapist, 1 occupational therapist, and 2 clinical assistants, with Year 1 revenue of $2.318 million and EBITDA of $1.115 million.\"\u003eRuns with 2 rheumatologists, 2 infusion nurses, 1 physical therapist, 1 occupational therapist, and 2 clinical assistants, with Year 1 revenue of $2.318 million and EBITDA of $1.115 million.\u003c\/td\u003e\n\u003ctd data-export-value=\"Moves closer to Year 5 scale with 6 rheumatologists, 5 infusion nurses, 4 physical therapists, 2 occupational therapists, and 6 clinical assistants, with Year 5 revenue of $12.327 million and EBITDA of $9.286 million.\"\u003eMoves closer to Year 5 scale with 6 rheumatologists, 5 infusion nurses, 4 physical therapists, 2 occupational therapists, and 6 clinical assistants, with Year 5 revenue of $12.327 million and EBITDA of $9.286 million.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Cost drivers\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-drivers\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-cost-drivers.svg\" alt=\"Cost drivers icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eCost drivers\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Lower infusion use; tighter staffing; lower capacity; smaller marketing spend; fewer billed procedures\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003eLower infusion use\u003c\/li\u003e\n\u003cli\u003etighter staffing\u003c\/li\u003e\n\u003cli\u003elower capacity\u003c\/li\u003e\n\u003cli\u003esmaller marketing spend\u003c\/li\u003e\n\u003cli\u003efewer billed procedures\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003ctd data-export-value=\"Year 1 capacity; balanced service mix; 2 rheumatologists; 2 infusion nurses; owner-clinician salary\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003eYear 1 capacity\u003c\/li\u003e\n\u003cli\u003ebalanced service mix\u003c\/li\u003e\n\u003cli\u003e2 rheumatologists\u003c\/li\u003e\n\u003cli\u003e2 infusion nurses\u003c\/li\u003e\n\u003cli\u003eowner-clinician salary\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003ctd data-export-value=\"Year 5 capacity; 6 rheumatologists; 5 infusion nurses; higher visit volume; larger support team\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003eYear 5 capacity\u003c\/li\u003e\n\u003cli\u003e6 rheumatologists\u003c\/li\u003e\n\u003cli\u003e5 infusion nurses\u003c\/li\u003e\n\u003cli\u003ehigher visit volume\u003c\/li\u003e\n\u003cli\u003elarger support team\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Owner income range\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-range\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-planning-range.svg\" alt=\"Owner income range icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eOwner income range\u003c\/span\u003e\u003cspan class=\"fml-scenario-row-subtitle\"\u003eBefore owner reserves\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"$180,000 - $240,000\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$180,000 - $240,000\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eLower income\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-export-value=\"$280,000\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$280,000\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eBase income\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-export-value=\"$400,000 - $600,000\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$400,000 - $600,000\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-warning\"\u003eHigher income\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Best fit\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-fit\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-best-fit.svg\" alt=\"Best fit icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eBest fit\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Use this to stress-test a slower start and thinner owner take-home.\"\u003eUse this to stress-test a slower start and thinner owner take-home.\u003c\/td\u003e\n\u003ctd data-export-value=\"Use this as the main plan for a stable opening year.\"\u003eUse this as the main plan for a stable opening year.\u003c\/td\u003e\n\u003ctd data-export-value=\"Use this to test upside if demand and staffing both scale cleanly.\"\u003eUse this to test upside if demand and staffing both scale cleanly.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003cdiv class=\"fml-scenario-table-note\"\u003e\n\u003cspan class=\"fml-scenario-table-note-icon\" aria-hidden=\"true\"\u003e!\u003c\/span\u003e\u003cp\u003e\u003cstrong\u003ePlanning note:\u003c\/strong\u003e Scenario ranges are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304462229747,"sku":"rheumatoid-arthritis-clinic-owner-makes","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/rheumatoid-arthritis-clinic-owner-makes.webp?v=1782691181","url":"https:\/\/financialmodelslab.com\/products\/rheumatoid-arthritis-clinic-owner-makes","provider":"Financial Models Lab","version":"1.0","type":"link"}